Aggarwal and Girard Analyze Data Amassed With Durvalumab in Unresectable Stage III NSCLC
Season 5, Episode 45, Sep 27, 2021, 07:15 PM
Dr. Aggarwal and Dr. Girard discuss the significance of the 5-year survival data from the pivotal PACIFIC trial and the real-world benefit of the study regimen in patients with unresectable stage III NSCLC.